title: P27/SKP-2 histochemical profile is relevant to malignant salivary gland tumors (MST) histogenesis and tumor grade.
abstract: Malignant salivary gland tumors (MST) represent over more than 24 distinct morphological subtypes. Most high grade tumors arise from the excretory duct portion of the salivary gland apparatus; the remainder from the intercalated duct portion. Altered p27/skp-2 expression has been associated with tumor aggressiveness and histologic differentiation. In our study, we analyzed p27/skp-2 expression proteins on series of malignant salivary gland tumors in order to assess their value as a histogenetic marker, which is relevant to tumor grade. 61 MST cases were segregated by proposed histogenesis and immunohistochemistry was performed using antibodies directed against p27 and skp-2. MST of proposed intercalated duct origin (n=27) showed strong p27 expression (n=25/27; 93%) in the vast majority of cases and all cases weakly expressed skp-2. MST of proposed excretory duct origin (n=32) showed strong p27 expression (n=18/32; 56%) and moderately strong/strong skp-2 expression (n=18/32; 56%), respectively, in over half the cases. MST of intercalated duct origin showed evident p27/skp-2 inverse correlation. Differences in p27/skp-2 expression among the MST subtypes correlated with histogenesis and tumor grade, which reinforces the notion that tumor behavior is relevant to the portion of the salivary gland unit from which they arise. MST of proposed intercalated duct origin strongly expressed p27, and not skp-2, unlike MST of proposed excretory duct origin. The immunohistochemical profile of high grade mucoepidermoid carcinoma was distinct from its low/intermediate grade counterparts, suggesting a separate identity. These results may influence future decision making when formulating workable MST categorization schemes. Further studies on a larger series of MST are warranted in order to support the value of our findings.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Rambam Medical Center, 6 Ha'Aliya Street, P.O. Box 9602, 31096, Haifa, Israel. sjakrish@gmail.com
authors.forename: Sharon
authors.initials: S
authors.lastname: Akrish
authors.forename: Ofer
authors.initials: O
authors.lastname: Ben-Izhak
authors.forename: Micha
authors.initials: M
authors.lastname: Peled
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis*; D044786:S-Phase Kinase-Associated Proteins / Q000096:biosynthesis*; D012468:Salivary Gland Neoplasms / Q000378:metabolism* / Q000473:pathology*; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D018809:Proliferating Cell Nuclear Antigen; D044786:S-Phase Kinase-Associated Proteins; C413374:p27 antigen
references.citation: Br J Oral Maxillofac Surg. 2009 Dec;47(8):587-93
references.pmid: 19409681
references.citation: Arch Otolaryngol. 1984 Mar;110(3):172-6
references.pmid: 6322732
references.citation: Arch Pathol Lab Med. 2001 Jun;125(6):740-5
references.pmid: 11371224
references.citation: Arch Pathol. 1971 Dec;92(6):433-43
references.pmid: 4330584
references.citation: Cancer. 2005 Apr 1;103(7):1336-46
references.pmid: 15717322
references.citation: Acta Otolaryngol. 2002 Oct;122(7):758-64
references.pmid: 12484654
references.citation: Cancer. 2008 Oct 15;113(8):2082-9
references.pmid: 18720358
references.citation: J Laryngol Otol. 1989 Oct;103(10):939-44
references.pmid: 2685148
references.citation: Arch Otolaryngol. 1976 Jun;102(6):355-7
references.pmid: 1275803
references.citation: Ann Otol Rhinol Laryngol. 1992 Jan;101(1):102-4
references.pmid: 1728879
references.citation: Virchows Arch A Pathol Anat Histopathol. 1990;417(5):405-17
references.pmid: 2173253
references.citation: Oral Oncol. 2007 Feb;43(2):130-6
references.pmid: 16857410
references.citation: Pathobiology. 1999 Jul-Aug;67(4):169-73
references.pmid: 10738177
references.citation: Virchows Arch. 2007 May;450(5):567-74
references.pmid: 17431674
references.citation: Ann Otol Rhinol Laryngol. 1989 Feb;98(2):162-3
references.pmid: 2537053
references.citation: Oral Oncol. 2009 Dec;45(12):1044-50
references.pmid: 19729335
references.citation: J Oral Surg. 1977 Nov;35(11):904-6
references.pmid: 269933
references.citation: Am J Surg Pathol. 1984 Nov;8(11):803-20
references.pmid: 6209992
references.citation: Otolaryngol Clin North Am. 1977 Jun;10(2):297-307
references.pmid: 197465
references.citation: FASEB J. 2007 Sep;21(11):2807-17
references.pmid: 17475922
references.citation: Oral Dis. 2002 Sep;8(5):229-40
references.pmid: 12363107
references.citation: Acta Oncol. 2006;45(6):662-8
references.pmid: 16938808
references.citation: Head Neck. 2001 Apr;23(4):292-7
references.pmid: 11400230
references.citation: Int J Cancer. 2003 Jun 20;105(3):326-30
references.pmid: 12704665
references.citation: Cancer. 2008 Apr 1;112(7):1415-24
references.pmid: 18260093
references.citation: Oral Oncol. 2006 Nov;42(10):1005-10
references.pmid: 16757206
references.citation: Oral Oncol. 2002 Jul;38(5):437-40
references.pmid: 12110337
references.citation: Mod Pathol. 2002 Mar;15(3):298-323
references.pmid: 11904344
references.citation: Laryngoscope. 2008 Feb;118(2):258-62
references.pmid: 18030166
references.citation: Oncol Rep. 2005 Jun;13(6):1089-94
references.pmid: 15870926
references.citation: Acta Neuropathol. 2004 Jul;108(1):43-8
references.pmid: 15088099
references.citation: Cancer Immunol Immunother. 2009 Mar;58(3):469-73
references.pmid: 18663445
references.citation: Asian Pac J Cancer Prev. 2005 Oct-Dec;6(4):527-30
references.pmid: 16436005